Balyasny Asset Management »

Aeglea Biotherapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.4M 74k 32.76
2024-09-30 $6.7M 228k 29.41
2024-06-30 $6.4M 273k 23.51
2024-03-31 $1.2M 32k 37.93

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Tesla Motors Call Option (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr State Street Fin (XLF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vaneck Etf Trust Semiconductr Etf (SMH)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)

View all positions for Balyasny Asset Management

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Vanguard Group
Fairmount Funds Management
VR Adviser
Capital Research and Management Company - Division 3
Perceptive Advisors
Driehaus Capital Management
Commodore Capital
State Street Corporation
TCG Crossover Management
Tang Capital Management
Geode Capital Management
Braidwell

View all funds holding Aeglea Biotherapeutics